Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
7.85
+0.62 (8.58%)
At close: May 16, 2025, 4:00 PM
7.84
-0.01 (-0.13%)
After-hours: May 16, 2025, 7:38 PM EDT
Replimune Group Employees
Replimune Group had 331 employees as of March 31, 2024. The number of employees increased by 47 or 16.55% compared to the previous year.
Employees
331
Change (1Y)
47
Growth (1Y)
16.55%
Revenue / Employee
n/a
Profits / Employee
-$689,553
Market Cap
604.57M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
REPL News
- 1 day ago - Replimune Announces Dates for Fiscal Fourth Quarter and Year End 2025 Financial Results and Upcoming Investor Day - GlobeNewsWire
- 8 days ago - Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 10 days ago - Sibylla Biotech Appoints Former Bayer CEO, Dieter Weinand, as Chairman of the Board of Directors - GlobeNewsWire
- 19 days ago - Replimune: Scope Goes Beyond That Of RP1 Oncolytic Targeting For Melanoma - Seeking Alpha
- 5 weeks ago - Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - Replimune: A Misunderstood Contender In Oncolytics - Seeking Alpha
- 3 months ago - Replimune Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 months ago - Replimune to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire